Drugmakers Beat Doc Request In Diabetes Drug MDL

By Lance Duroni (October 7, 2014, 1:29 PM EDT) -- A California federal judge on Monday refused to force Eli Lilly and Co., Novo Nordisk Inc. and other drugmakers to turn over documents concerning pancreatic cancer events to plaintiffs in multidistrict litigation over diabetes drugs, ruling that the materials aren't relevant to the central disputes in the case....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!